El-Mahrouky A S, Dawson D V, Paulson D F, Sanfilippo F
J Urol. 1983 Mar;129(3):499-501. doi: 10.1016/s0022-5347(17)52200-4.
A group of 40 patients with bilharzial bladder cancer underwent quantitative skin testing with dinitrochlorobenzene and purified protein derivative of tuberculin before radical surgery. Correlations were made between various clinical parameters, patient outcome, skin test results and pathologic changes in the resected bladder and draining lymph nodes. Striking associations between dinitrochlorobenzene responses and tumor stage, tumor recurrence and several specific parameters of lymph node stimulation were found, while no correlations were made with the pathologic grade, size or type of tumor, degree of schistosomal infestation or tumor bed inflammation. Purified protein derivative responses showed no correlation with any parameter examined. Patient outcome also showed a good correlation with tumor stage and draining lymph node reaction. These findings indicate that dinitrochlorobenzene skin testing as a presumptive test of cell-mediated immunity may represent a good predictor of clinical outcome in patients with bilharzial bladder cancer, and correlates well with draining lymph node stimulation.
一组40例血吸虫性膀胱癌患者在根治性手术前接受了二硝基氯苯和结核菌素纯蛋白衍生物的定量皮肤试验。对各种临床参数、患者预后、皮肤试验结果以及切除膀胱和引流淋巴结的病理变化进行了相关性分析。发现二硝基氯苯反应与肿瘤分期、肿瘤复发以及淋巴结刺激的几个特定参数之间存在显著关联,而与肿瘤的病理分级、大小或类型、血吸虫感染程度或肿瘤床炎症无相关性。结核菌素纯蛋白衍生物反应与所检查的任何参数均无相关性。患者预后也与肿瘤分期和引流淋巴结反应密切相关。这些发现表明,二硝基氯苯皮肤试验作为细胞介导免疫的一种推定试验,可能是血吸虫性膀胱癌患者临床预后的良好预测指标,并且与引流淋巴结刺激密切相关。